| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLCO2B1 CFTR SLC24A3 SLC35B2 MFSD4B SLC7A11 SLC7A9 SLCO5A1 SLC8B1 SLC24A4 CLCN7 ABCB11 SLC7A5 SLC37A2 SLC16A11 ATP2A1 ATP5F1B | 5.59e-10 | 477 | 106 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO2B1 SLC24A3 SLC35B2 MFSD4B SLC7A11 SLC7A9 SLCO5A1 SLC8B1 SLC24A4 CLCN7 SLC7A5 SLC37A2 SLC16A11 | 5.96e-09 | 296 | 106 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | CEACAM5 SLCO2B1 CFTR SLC35B2 SLC7A11 CEACAM1 SLC7A9 SLCO5A1 ABCB11 SLC7A5 SLC37A2 SLC16A11 | 5.13e-08 | 293 | 106 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | antiporter activity | SLC24A3 SLC35B2 SLC7A11 SLC7A9 SLC8B1 SLC24A4 CLCN7 SLC7A5 SLC37A2 | 5.15e-08 | 138 | 106 | 9 | GO:0015297 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CEACAM5 SLCO2B1 CFTR SLC24A3 SLC35B2 MFSD4B SLC7A11 AQP6 CEACAM1 SLC7A9 SLCO5A1 SLC8B1 SLC24A4 CLCN7 SCN2B ABCB11 SLC7A5 SLC37A2 SLC16A11 SLC7A5P1 ATP2A1 ATP5F1B | 2.02e-07 | 1180 | 106 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CEACAM5 SLCO2B1 CFTR SLC24A3 SLC35B2 MFSD4B SLC7A11 AQP6 CEACAM1 SLC7A9 SLCO5A1 SLC8B1 SLC24A4 CLCN7 SCN2B NPC1L1 ABCB11 SLC7A5 SLC37A2 SLC16A11 SLC7A5P1 ATP2A1 ATP5F1B | 2.21e-07 | 1289 | 106 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.25e-07 | 49 | 106 | 6 | GO:0042605 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.59e-07 | 12 | 106 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | CEACAM5 SLCO2B1 SLC7A11 CEACAM1 SLC7A9 ABCB11 SLC7A5 SLC16A11 | 1.47e-05 | 207 | 106 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | CEACAM5 SLCO2B1 SLC7A11 CEACAM1 SLC7A9 ABCB11 SLC7A5 SLC16A11 | 1.52e-05 | 208 | 106 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.70e-05 | 10 | 106 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | CTP synthase activity | 2.79e-05 | 2 | 106 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.08e-05 | 34 | 106 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 4.00e-05 | 13 | 106 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 9.46e-05 | 138 | 106 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.18e-04 | 90 | 106 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.55e-04 | 20 | 106 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 2.76e-04 | 5 | 106 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | peptide binding | 2.96e-04 | 318 | 106 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | UBA5 CEACAM5 IMPA1 HLA-E HLA-F CEACAM1 SLC8B1 GRHPR NPC1L1 NECTIN2 CTBP1 ATP2A1 JAM3 | 3.80e-04 | 815 | 106 | 13 | GO:0042803 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.81e-04 | 29 | 106 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.26e-04 | 70 | 106 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | antigen binding | 5.32e-04 | 190 | 106 | 6 | GO:0003823 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.83e-04 | 127 | 106 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.16e-04 | 73 | 106 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 6.45e-04 | 32 | 106 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 9.81e-04 | 9 | 106 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 9.81e-04 | 9 | 106 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | guanylate cyclase activity | 1.22e-03 | 10 | 106 | 2 | GO:0004383 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.22e-03 | 10 | 106 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.22e-03 | 10 | 106 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.22e-03 | 10 | 106 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 1.49e-03 | 11 | 106 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.54e-03 | 43 | 106 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | protein dimerization activity | UBA5 CEACAM5 IMPA1 HLA-E HLA-F CEACAM4 CEACAM1 SLC7A9 SLC8B1 GRHPR NPC1L1 NECTIN2 CTBP1 ATP2A1 JAM3 | 1.73e-03 | 1205 | 106 | 15 | GO:0046983 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.44e-03 | 14 | 106 | 2 | GO:0005130 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.72e-03 | 109 | 106 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 3.60e-03 | 17 | 106 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | MHC protein binding | 3.63e-03 | 58 | 106 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 3.81e-03 | 59 | 106 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.94e-03 | 196 | 106 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 4.04e-03 | 18 | 106 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 4.19e-03 | 61 | 106 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.50e-03 | 19 | 106 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 6.40e-03 | 71 | 106 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.57e-03 | 23 | 106 | 2 | GO:0034235 | |
| GeneOntologyMolecularFunction | NAD binding | 6.91e-03 | 73 | 106 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CFTR SLC24A3 AQP6 SLC8B1 SLC24A4 CLCN7 SCN2B SLC37A2 ATP2A1 ATP5F1B | 7.04e-03 | 758 | 106 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | cyclase activity | 7.14e-03 | 24 | 106 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 7.14e-03 | 24 | 106 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 7.55e-03 | 766 | 106 | 10 | GO:0016491 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 7.73e-03 | 25 | 106 | 2 | GO:0016849 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 3.01e-07 | 53 | 106 | 6 | GO:0001914 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.60e-06 | 70 | 106 | 6 | GO:0001913 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.70e-06 | 111 | 106 | 7 | GO:0002709 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.38e-06 | 42 | 106 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | organic anion transport | CEACAM5 SLCO2B1 CFTR SLC35B2 SLC7A11 CEACAM1 SLC7A9 SLCO5A1 ABCB11 SLC7A5 SLC37A2 SLC16A11 SLC7A5P1 | 2.42e-06 | 515 | 106 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.56e-06 | 124 | 106 | 7 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 4.37e-06 | 83 | 106 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | PECR PLB1 IMPA1 ACO2 CFTR DUOX2 SLC7A11 ADH6 ADH7 NPC1L1 DISP3 ABCB11 SLC37A2 PRKG2 | 5.16e-06 | 641 | 106 | 14 | GO:1901615 |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 5.19e-06 | 49 | 106 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 5.75e-06 | 50 | 106 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.01e-05 | 56 | 106 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.02e-05 | 96 | 106 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.09e-05 | 147 | 106 | 7 | GO:0031341 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | PECR CEACAM5 ACO2 ETFDH L2HGDH DDO SLC7A11 AWAT1 CEACAM1 GGT5 ADH6 ADH7 CTPS2 GRHPR ABCB11 CTPS1 UEVLD | 2.04e-05 | 1035 | 106 | 17 | GO:0019752 |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.14e-05 | 163 | 106 | 7 | GO:0002456 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 2.62e-05 | 2 | 106 | 2 | GO:0044210 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 2.66e-05 | 232 | 106 | 8 | GO:0002706 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | PECR CEACAM5 ACO2 ETFDH L2HGDH DDO SLC7A11 AWAT1 CEACAM1 GGT5 ADH6 ADH7 CTPS2 GRHPR ABCB11 CTPS1 UEVLD | 2.70e-05 | 1058 | 106 | 17 | GO:0043436 |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated immunity | 2.71e-05 | 34 | 106 | 4 | GO:0002710 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | PECR CEACAM5 ACO2 ETFDH L2HGDH DDO SLC7A11 AWAT1 CEACAM1 GGT5 ADH6 ADH7 CTPS2 GRHPR ABCB11 CTPS1 UEVLD | 2.90e-05 | 1064 | 106 | 17 | GO:0006082 |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.24e-05 | 71 | 106 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 3.44e-05 | 313 | 106 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | sulfur amino acid transport | 3.63e-05 | 13 | 106 | 3 | GO:0000101 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.96e-05 | 74 | 106 | 5 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.51e-05 | 76 | 106 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 4.51e-05 | 76 | 106 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 5.15e-05 | 187 | 106 | 7 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.22e-05 | 40 | 106 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 5.24e-05 | 412 | 106 | 10 | GO:0006066 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 5.43e-05 | 79 | 106 | 5 | GO:0001912 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.76e-05 | 41 | 106 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 5.76e-05 | 41 | 106 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.77e-05 | 80 | 106 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of presynapse assembly | 6.35e-05 | 42 | 106 | 4 | GO:1905606 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 7.04e-05 | 16 | 106 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 8.51e-05 | 17 | 106 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 8.51e-05 | 17 | 106 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 9.10e-05 | 88 | 106 | 5 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 9.11e-05 | 46 | 106 | 4 | GO:0099174 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 9.92e-05 | 47 | 106 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 9.92e-05 | 47 | 106 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.02e-04 | 18 | 106 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.15e-04 | 286 | 106 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HFE MPZ PDCD1 CEACAM5 HLA-DQA1 LRFN3 HLA-E ESAM IGSF11 SLC7A11 CEACAM1 LRFN4 LRFN5 NECTIN2 JAM3 PEAR1 | 1.20e-04 | 1077 | 106 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | HFE PDCD1 CEACAM5 HLA-DQA1 HLA-E ADAM22 CEACAM1 JAM3 ATP5F1B | 1.37e-04 | 375 | 106 | 9 | GO:0007162 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.48e-04 | 52 | 106 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 1.56e-04 | 4 | 106 | 2 | GO:0002488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 1.56e-04 | 4 | 106 | 2 | GO:0002489 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.64e-04 | 21 | 106 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.64e-04 | 21 | 106 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 1.96e-04 | 309 | 106 | 8 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | HFE PLB1 CFTR CEACAM4 DUOX2 DDO ADH6 ADH7 SLC8B1 SYTL4 SLC7A5 ENPEP | 2.05e-04 | 684 | 106 | 12 | GO:0010817 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 2.09e-04 | 105 | 106 | 5 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.13e-04 | 235 | 106 | 7 | GO:0002822 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.17e-04 | 23 | 106 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 2.17e-04 | 23 | 106 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 2.18e-04 | 166 | 106 | 6 | GO:0002698 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 2.26e-04 | 58 | 106 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | cytokine production involved in immune response | 2.33e-04 | 168 | 106 | 6 | GO:0002367 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 2.43e-04 | 240 | 106 | 7 | GO:0002695 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | HFE PDCD1 CEACAM5 HLA-E HLA-F CEACAM4 MR1 CEACAM1 NECTIN2 SLC7A5 | 2.43e-04 | 497 | 106 | 10 | GO:0002697 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.47e-04 | 24 | 106 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.47e-04 | 24 | 106 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 2.49e-04 | 109 | 106 | 5 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 2.56e-04 | 171 | 106 | 6 | GO:0050868 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 2.58e-04 | 60 | 106 | 4 | GO:0099054 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.59e-04 | 5 | 106 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 2.59e-04 | 5 | 106 | 2 | GO:0002481 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 2.59e-04 | 5 | 106 | 2 | GO:0002477 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CEACAM5 SLCO2B1 SLC7A11 CEACAM1 SLC7A9 ABCB11 SLC7A5 SLC16A11 SLC7A5P1 | 2.66e-04 | 410 | 106 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CEACAM5 SLCO2B1 SLC7A11 CEACAM1 SLC7A9 ABCB11 SLC7A5 SLC16A11 SLC7A5P1 | 2.76e-04 | 412 | 106 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.79e-04 | 25 | 106 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.79e-04 | 25 | 106 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.79e-04 | 25 | 106 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | lipid transport | CEACAM5 SLCO2B1 VPS13C CFTR CEACAM1 APOLD1 NPC1L1 VPS13A DISP3 ABCB11 | 2.80e-04 | 506 | 106 | 10 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 3.26e-04 | 252 | 106 | 7 | GO:0002819 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 3.51e-04 | 65 | 106 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.72e-04 | 66 | 106 | 4 | GO:0002823 | |
| GeneOntologyBiologicalProcess | L-cystine transport | 3.87e-04 | 6 | 106 | 2 | GO:0015811 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 4.31e-04 | 264 | 106 | 7 | GO:0050866 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 4.75e-04 | 192 | 106 | 6 | GO:1903038 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 4.91e-04 | 71 | 106 | 4 | GO:0002820 | |
| GeneOntologyBiologicalProcess | sperm mitochondrion organization | 5.40e-04 | 7 | 106 | 2 | GO:0030382 | |
| GeneOntologyBiologicalProcess | regulation of chloride transport | 5.40e-04 | 7 | 106 | 2 | GO:2001225 | |
| GeneOntologyBiologicalProcess | presynapse organization | 5.46e-04 | 73 | 106 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 5.87e-04 | 32 | 106 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | lipid localization | CEACAM5 SLCO2B1 VPS13C CFTR CEACAM1 APOLD1 NPC1L1 VPS13A DISP3 ABCB11 | 6.64e-04 | 565 | 106 | 10 | GO:0010876 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 7.18e-04 | 8 | 106 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase biosynthetic process | 7.18e-04 | 8 | 106 | 2 | GO:0019856 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 7.60e-04 | 139 | 106 | 5 | GO:0019882 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 7.79e-04 | 211 | 106 | 6 | GO:0051250 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production involved in immune response | 9.19e-04 | 145 | 106 | 5 | GO:0002718 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle cell apoptotic process | 9.20e-04 | 9 | 106 | 2 | GO:1905460 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell activation | 9.20e-04 | 9 | 106 | 2 | GO:0033005 | |
| GeneOntologyBiologicalProcess | cell killing | 1.05e-03 | 307 | 106 | 7 | GO:0001906 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.06e-03 | 87 | 106 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 1.07e-03 | 150 | 106 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.07e-03 | 150 | 106 | 5 | GO:0002824 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.10e-03 | 151 | 106 | 5 | GO:0002832 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 1.14e-03 | 40 | 106 | 3 | GO:0045954 | |
| GeneOntologyCellularComponent | cell surface | HFE PDCD1 LRFN1 CEACAM5 HLA-DQA1 LRFN3 CFTR CEACAM3 HLA-E HLA-F CEACAM4 MR1 DUOX2 SLC7A11 CEACAM1 LRFN4 LRFN2 SIGLEC7 LRFN5 NECTIN2 ABCB11 SDC3 SLC7A5 TMEM123 ENPEP JAM3 ATP5F1B | 7.44e-12 | 1111 | 107 | 27 | GO:0009986 |
| GeneOntologyCellularComponent | apical part of cell | HFE PLB1 CEACAM5 SLCO2B1 CFTR CEACAM4 DUOX2 MFSD4B SLC7A11 AQP6 CEACAM1 SLC7A9 SLC24A4 SYTL4 NPC1L1 ABCB11 SLC7A5 PRKG2 ENPEP | 1.56e-10 | 592 | 107 | 19 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | PLB1 CEACAM5 SLCO2B1 CFTR CEACAM4 DUOX2 MFSD4B AQP6 CEACAM1 SLC7A9 SLC24A4 SYTL4 NPC1L1 ABCB11 SLC7A5 PRKG2 ENPEP | 4.48e-10 | 487 | 107 | 17 | GO:0016324 |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.33e-07 | 10 | 107 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.93e-07 | 26 | 107 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | external side of plasma membrane | HFE PDCD1 CEACAM5 HLA-DQA1 HLA-E HLA-F CEACAM4 MR1 CEACAM1 SIGLEC7 SLC7A5 TMEM123 ENPEP | 2.53e-06 | 519 | 107 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | recycling endosome | 1.89e-05 | 222 | 107 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | brush border membrane | 6.76e-05 | 83 | 107 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | cytoophidium | 7.76e-05 | 3 | 107 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | brush border | 1.32e-04 | 152 | 107 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | basal part of cell | 1.42e-04 | 378 | 107 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | guanylate cyclase complex, soluble | 1.55e-04 | 4 | 107 | 2 | GO:0008074 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.58e-04 | 157 | 107 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.42e-04 | 320 | 107 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | HLA-DQA1 VPS13C FPR2 CFTR CEACAM3 HLA-E HLA-F MR1 AQP6 CEACAM1 GPR161 SYTL4 NPC1L1 VPS13A DISP3 ABCB11 UEVLD | 3.37e-04 | 1307 | 107 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | cell projection membrane | PLB1 CEACAM5 SLC7A11 CEACAM1 SLC7A9 GPR161 NPC1L1 SLC7A5 ENPEP | 3.74e-04 | 431 | 107 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | vesicle membrane | HLA-DQA1 VPS13C FPR2 CFTR CEACAM3 HLA-E HLA-F MR1 AQP6 CEACAM1 GPR161 SYTL4 NPC1L1 VPS13A DISP3 ABCB11 UEVLD | 3.94e-04 | 1325 | 107 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | microvillus | 4.28e-04 | 123 | 107 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | basal plasma membrane | 4.75e-04 | 354 | 107 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | side of membrane | HFE PDCD1 CEACAM5 HLA-DQA1 HLA-E HLA-F CEACAM4 MR1 CEACAM1 SIGLEC7 SLC7A5 TMEM123 ENPEP | 5.29e-04 | 875 | 107 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 5.36e-04 | 7 | 107 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.92e-04 | 201 | 107 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | lysosomal membrane | 6.16e-04 | 462 | 107 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 6.16e-04 | 462 | 107 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 7.57e-04 | 35 | 107 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | endosome | HFE OR2A7 HLA-DQA1 VPS13C CFTR HLA-E HLA-F MR1 GPR161 SYTL4 OR2A4 VPS13A ABCB11 TOLLIP UEVLD | 8.77e-04 | 1167 | 107 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | myelin sheath | 8.83e-04 | 217 | 107 | 6 | GO:0043209 | |
| GeneOntologyCellularComponent | microvillus membrane | 9.66e-04 | 38 | 107 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.02e-03 | 223 | 107 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.18e-03 | 507 | 107 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | membrane protein complex | HFE CEACAM5 HLA-DQA1 CFTR HLA-E HLA-F MR1 DUOX2 CEACAM1 CLCN7 SCN2B TIMM50 SLC7A5 ATP2A1 MICOS10 ATP5F1B UEVLD | 1.54e-03 | 1498 | 107 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.91e-03 | 48 | 107 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.27e-03 | 14 | 107 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UBA5 HLA-DQA1 VPS13C CFTR HLA-E HLA-F MR1 SLC35B2 AWAT1 NOMO2 VPS13A DISP3 SLC37A2 SLC16A11 ATP2A1 | 2.41e-03 | 1293 | 107 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UBA5 HLA-DQA1 VPS13C CFTR HLA-E HLA-F MR1 SLC35B2 AWAT1 NOMO2 VPS13A DISP3 SLC37A2 SLC16A11 ATP2A1 | 2.52e-03 | 1299 | 107 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.64e-03 | 112 | 107 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | lysosome | HLA-DQA1 VPS13C CFTR HLA-E HLA-F CLCN7 VPS13A TOLLIP SDC3 SLC7A5 ENPEP | 2.94e-03 | 811 | 107 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HLA-DQA1 VPS13C CFTR HLA-E HLA-F CLCN7 VPS13A TOLLIP SDC3 SLC7A5 ENPEP | 2.94e-03 | 811 | 107 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.97e-03 | 16 | 107 | 2 | GO:0070021 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 2.97e-03 | 16 | 107 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UBA5 HLA-DQA1 VPS13C CFTR HLA-E HLA-F MR1 SLC35B2 AWAT1 NOMO2 VPS13A DISP3 SLC37A2 SLC16A11 ATP2A1 | 3.09e-03 | 1327 | 107 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 3.36e-03 | 17 | 107 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | endosome membrane | 3.77e-03 | 602 | 107 | 9 | GO:0010008 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 4.33e-03 | 64 | 107 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.71e-03 | 212 | 107 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.99e-03 | 141 | 107 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 6.12e-03 | 23 | 107 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 6.12e-03 | 23 | 107 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HFE CEACAM5 HLA-DQA1 HLA-E HLA-F MR1 DUOX2 CEACAM1 SCN2B SLC7A5 | 6.99e-03 | 785 | 107 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | vacuole | HLA-DQA1 VPS13C CFTR HLA-E HLA-F CLCN7 VPS13A TOLLIP SDC3 SLC7A5 ENPEP | 7.08e-03 | 913 | 107 | 11 | GO:0005773 |
| GeneOntologyCellularComponent | postsynaptic density | 8.53e-03 | 451 | 107 | 7 | GO:0014069 | |
| Domain | - | IGSF8 HFE MPZ FLNB PDCD1 LRFN1 CEACAM5 HLA-DQA1 LRFN3 CEACAM3 HLA-E HLA-F CEACAM4 MR1 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 NOMO2 LRFN5 SCN2B NECTIN2 JAM3 EPHA1 | 2.76e-16 | 663 | 105 | 27 | 2.60.40.10 |
| Domain | IG_LIKE | IGSF8 HFE MPZ PDCD1 LRFN1 CEACAM5 HLA-DQA1 LRFN3 CEACAM3 HLA-E HLA-F CEACAM4 MR1 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 LRFN5 SCN2B NECTIN2 JAM3 | 2.85e-16 | 491 | 105 | 24 | PS50835 |
| Domain | Ig-like_dom | IGSF8 HFE MPZ PDCD1 LRFN1 CEACAM5 HLA-DQA1 LRFN3 CEACAM3 HLA-E HLA-F CEACAM4 MR1 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 LRFN5 SCN2B NECTIN2 JAM3 | 4.90e-16 | 503 | 105 | 24 | IPR007110 |
| Domain | Ig-like_fold | IGSF8 HFE MPZ FLNB PDCD1 LRFN1 CEACAM5 HLA-DQA1 LRFN3 CEACAM3 HLA-E HLA-F CEACAM4 MR1 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 NOMO2 LRFN5 SCN2B NECTIN2 JAM3 EPHA1 | 1.30e-15 | 706 | 105 | 27 | IPR013783 |
| Domain | IG | IGSF8 MPZ PDCD1 LRFN1 CEACAM5 LRFN3 CEACAM3 CEACAM4 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 LRFN5 SCN2B NECTIN2 JAM3 | 2.11e-12 | 421 | 105 | 19 | SM00409 |
| Domain | Ig_sub | IGSF8 MPZ PDCD1 LRFN1 CEACAM5 LRFN3 CEACAM3 CEACAM4 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 SIGLEC7 LRFN5 SCN2B NECTIN2 JAM3 | 2.11e-12 | 421 | 105 | 19 | IPR003599 |
| Domain | V-set | IGSF8 MPZ PDCD1 CEACAM5 CEACAM3 CEACAM4 ESAM IGSF11 CEACAM1 SIGLEC7 SCN2B NECTIN2 JAM3 | 3.41e-11 | 184 | 105 | 13 | PF07686 |
| Domain | Ig_V-set | IGSF8 MPZ PDCD1 CEACAM5 CEACAM3 CEACAM4 ESAM IGSF11 CEACAM1 SIGLEC7 SCN2B NECTIN2 JAM3 | 9.11e-11 | 199 | 105 | 13 | IPR013106 |
| Domain | Ig_I-set | LRFN1 CEACAM5 LRFN3 ESAM IGSF11 CEACAM1 LRFN4 LRFN2 SIGLEC7 LRFN5 JAM3 | 9.80e-09 | 190 | 105 | 11 | IPR013098 |
| Domain | I-set | LRFN1 CEACAM5 LRFN3 ESAM IGSF11 CEACAM1 LRFN4 LRFN2 SIGLEC7 LRFN5 JAM3 | 9.80e-09 | 190 | 105 | 11 | PF07679 |
| Domain | IGc2 | LRFN1 CEACAM5 LRFN3 ESAM IGSF11 CEACAM1 LRFN4 LRFN2 SIGLEC7 LRFN5 JAM3 | 8.73e-08 | 235 | 105 | 11 | SM00408 |
| Domain | Ig_sub2 | LRFN1 CEACAM5 LRFN3 ESAM IGSF11 CEACAM1 LRFN4 LRFN2 SIGLEC7 LRFN5 JAM3 | 8.73e-08 | 235 | 105 | 11 | IPR003598 |
| Domain | D-isomer_DH_NAD-bd | 1.71e-06 | 5 | 105 | 3 | IPR006140 | |
| Domain | MHC_I/II-like_Ag-recog | 2.21e-06 | 38 | 105 | 5 | IPR011162 | |
| Domain | MHC_I | 5.24e-06 | 21 | 105 | 4 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 5.24e-06 | 21 | 105 | 4 | IPR001039 | |
| Domain | NAD(P)-bd_dom | 5.99e-06 | 173 | 105 | 8 | IPR016040 | |
| Domain | - | 9.19e-06 | 24 | 105 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 9.19e-06 | 24 | 105 | 4 | IPR011161 | |
| Domain | C1-set | 1.30e-05 | 54 | 105 | 5 | PF07654 | |
| Domain | NaCa_Exmemb | 1.42e-05 | 9 | 105 | 3 | IPR004837 | |
| Domain | Na_Ca_ex | 1.42e-05 | 9 | 105 | 3 | PF01699 | |
| Domain | IGc1 | 1.55e-05 | 56 | 105 | 5 | SM00407 | |
| Domain | Ig_C1-set | 1.85e-05 | 58 | 105 | 5 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.85e-05 | 58 | 105 | 5 | IPR003006 | |
| Domain | IG_MHC | 2.18e-05 | 60 | 105 | 5 | PS00290 | |
| Domain | CTP_synthase_N | 3.13e-05 | 2 | 105 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 3.13e-05 | 2 | 105 | 2 | IPR033828 | |
| Domain | CTP_synthase | 3.13e-05 | 2 | 105 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 3.13e-05 | 2 | 105 | 2 | PF06418 | |
| Domain | AA_permease_2 | 4.74e-05 | 13 | 105 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 4.74e-05 | 13 | 105 | 3 | IPR002293 | |
| Domain | - | 4.74e-05 | 169 | 105 | 7 | 3.40.50.720 | |
| Domain | VPS13 | 9.36e-05 | 3 | 105 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 9.36e-05 | 3 | 105 | 2 | PF16910 | |
| Domain | VPS13 | 9.36e-05 | 3 | 105 | 2 | PF16908 | |
| Domain | VPS13_N2 | 9.36e-05 | 3 | 105 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 9.36e-05 | 3 | 105 | 2 | IPR031642 | |
| Domain | D-isomer_DH_CS1 | 9.36e-05 | 3 | 105 | 2 | IPR029752 | |
| Domain | L_AA_transporter | 9.36e-05 | 3 | 105 | 2 | IPR004760 | |
| Domain | Cys-rich_flank_reg_C | 1.53e-04 | 90 | 105 | 5 | IPR000483 | |
| Domain | LRRCT | 1.53e-04 | 90 | 105 | 5 | SM00082 | |
| Domain | D_2_HYDROXYACID_DH_2 | 1.86e-04 | 4 | 105 | 2 | PS00670 | |
| Domain | D_2_HYDROXYACID_DH_3 | 1.86e-04 | 4 | 105 | 2 | PS00671 | |
| Domain | VPS13_C | 1.86e-04 | 4 | 105 | 2 | PF16909 | |
| Domain | SHR-BD | 1.86e-04 | 4 | 105 | 2 | IPR009543 | |
| Domain | 2-Hacid_dh_C | 1.86e-04 | 4 | 105 | 2 | PF02826 | |
| Domain | D-isomer_2_OHA_DH_cat_dom | 1.86e-04 | 4 | 105 | 2 | IPR006139 | |
| Domain | HNOB | 1.86e-04 | 4 | 105 | 2 | PF07700 | |
| Domain | VPS13_C | 1.86e-04 | 4 | 105 | 2 | IPR031645 | |
| Domain | D-isomer_DH_CS | 1.86e-04 | 4 | 105 | 2 | IPR029753 | |
| Domain | 2-Hacid_dh | 1.86e-04 | 4 | 105 | 2 | PF00389 | |
| Domain | D_2_HYDROXYACID_DH_1 | 1.86e-04 | 4 | 105 | 2 | PS00065 | |
| Domain | SHR-BD | 1.86e-04 | 4 | 105 | 2 | PF06650 | |
| Domain | AA-permease/SLC12A_dom | 2.46e-04 | 22 | 105 | 3 | IPR004841 | |
| Domain | AA_permease | 2.46e-04 | 22 | 105 | 3 | PF00324 | |
| Domain | ATG_C | 3.10e-04 | 5 | 105 | 2 | PF09333 | |
| Domain | GATase | 3.10e-04 | 5 | 105 | 2 | PF00117 | |
| Domain | K/Na/Ca-exchanger | 3.10e-04 | 5 | 105 | 2 | IPR004481 | |
| Domain | Autophagy-rel_C | 3.10e-04 | 5 | 105 | 2 | IPR015412 | |
| Domain | GATASE | 4.63e-04 | 6 | 105 | 2 | IPR017926 | |
| Domain | MHC_I_a_C | 4.63e-04 | 6 | 105 | 2 | IPR010579 | |
| Domain | HNOB_dom_associated | 4.63e-04 | 6 | 105 | 2 | IPR011645 | |
| Domain | GATASE_TYPE_1 | 4.63e-04 | 6 | 105 | 2 | PS51273 | |
| Domain | HNOBA | 4.63e-04 | 6 | 105 | 2 | PF07701 | |
| Domain | MHC_I_C | 4.63e-04 | 6 | 105 | 2 | PF06623 | |
| Domain | IGv | 8.44e-04 | 75 | 105 | 4 | SM00406 | |
| Domain | VPS13_N | 8.57e-04 | 8 | 105 | 2 | IPR026854 | |
| Domain | Chorein_N | 8.57e-04 | 8 | 105 | 2 | PF12624 | |
| Domain | Myelin_P0-rel | 8.57e-04 | 8 | 105 | 2 | IPR000920 | |
| Domain | NO_sig/Golgi_transp_ligand-bd | 8.57e-04 | 8 | 105 | 2 | IPR024096 | |
| Domain | ADH_Zn_CS | 8.57e-04 | 8 | 105 | 2 | IPR002328 | |
| Domain | ADH_ZINC | 8.57e-04 | 8 | 105 | 2 | PS00059 | |
| Domain | FN3 | 9.11e-04 | 199 | 105 | 6 | PS50853 | |
| Domain | MFS_dom | 9.60e-04 | 134 | 105 | 5 | IPR020846 | |
| Domain | Heme_NO-bd | 1.10e-03 | 9 | 105 | 2 | IPR011644 | |
| Domain | Ptc/Disp | 1.10e-03 | 9 | 105 | 2 | IPR003392 | |
| Domain | Patched | 1.10e-03 | 9 | 105 | 2 | PF02460 | |
| Domain | FN3_dom | 1.17e-03 | 209 | 105 | 6 | IPR003961 | |
| Domain | - | 1.37e-03 | 10 | 105 | 2 | 3.40.50.880 | |
| Domain | Class_I_gatase-like | 1.99e-03 | 12 | 105 | 2 | IPR029062 | |
| Domain | FAD-dep_OxRdtase | 1.99e-03 | 12 | 105 | 2 | IPR006076 | |
| Domain | DAO | 1.99e-03 | 12 | 105 | 2 | PF01266 | |
| Domain | OA_transporter | 1.99e-03 | 12 | 105 | 2 | IPR004156 | |
| Domain | OATP | 1.99e-03 | 12 | 105 | 2 | PF03137 | |
| Domain | fn3 | 2.22e-03 | 162 | 105 | 5 | PF00041 | |
| Domain | LRRNT | 2.27e-03 | 98 | 105 | 4 | IPR000372 | |
| Domain | ZINC_PROTEASE | 2.27e-03 | 98 | 105 | 4 | PS00142 | |
| Domain | LRRNT | 2.27e-03 | 98 | 105 | 4 | SM00013 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | IPR000731 | |
| Domain | SSD | 2.35e-03 | 13 | 105 | 2 | PS50156 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.25e-03 | 177 | 105 | 5 | IPR003591 | |
| Domain | LRR_TYP | 3.25e-03 | 177 | 105 | 5 | SM00369 | |
| Domain | ADH_N | 3.57e-03 | 16 | 105 | 2 | PF08240 | |
| Domain | Disintegrin_CS | 3.57e-03 | 16 | 105 | 2 | IPR018358 | |
| Domain | ADH_N | 3.57e-03 | 16 | 105 | 2 | IPR013154 | |
| Domain | - | 3.86e-03 | 56 | 105 | 3 | 3.50.50.60 | |
| Domain | FN3 | 3.93e-03 | 185 | 105 | 5 | SM00060 | |
| Domain | A/G_cyclase_CS | 4.03e-03 | 17 | 105 | 2 | IPR018297 | |
| Domain | FAD/NAD-binding_dom | 4.05e-03 | 57 | 105 | 3 | IPR023753 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 9.13e-08 | 133 | 84 | 9 | M16476 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | CEACAM5 CEACAM4 ESAM SLC7A11 CEACAM1 SLC7A9 SDC3 SLC7A5 JAM3 | 3.99e-07 | 158 | 84 | 9 | MM14812 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | CEACAM5 CEACAM3 ESAM SLC7A11 CEACAM1 SLC7A9 SDC3 SLC7A5 JAM3 | 2.22e-06 | 194 | 84 | 9 | M16312 |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.28e-06 | 20 | 84 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.50e-06 | 21 | 84 | 4 | M27736 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO2B1 SLC24A3 SLC35B2 MFSD4B SLC7A11 SLC7A9 SLC8B1 SLC24A4 SLC7A5 | 1.68e-05 | 249 | 84 | 9 | M5988 |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 3.25e-05 | 11 | 84 | 3 | M27336 | |
| Pathway | WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY | 3.71e-05 | 32 | 84 | 4 | M42560 | |
| Pathway | REACTOME_HEMOSTASIS | CEACAM5 CEACAM3 ESAM SLC7A11 CEACAM1 SLC7A9 GUCY1A2 GUCY1B1 SYTL4 SDC3 SLC7A5 PRKG2 ATP2A1 JAM3 | 4.39e-05 | 679 | 84 | 14 | M8395 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.40e-05 | 108 | 84 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.64e-05 | 109 | 84 | 6 | MM15074 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 5.59e-05 | 13 | 84 | 3 | MM15078 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO2B1 SLC24A3 SLC35B2 SLC7A11 SLC7A9 SLC8B1 SLC24A4 SLC7A5 | 8.48e-05 | 238 | 84 | 8 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLCO2B1 CFTR SLC24A3 SLC35B2 MFSD4B SLC7A11 AQP6 SLC7A9 SLC8B1 SLC24A4 CLCN7 SLC7A5 ATP2A1 | 1.04e-04 | 736 | 84 | 14 | M27287 |
| Pathway | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | 2.90e-04 | 22 | 84 | 3 | M915 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 3.77e-04 | 24 | 84 | 3 | MM17215 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 4.27e-04 | 25 | 84 | 3 | M4974 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.18e-04 | 6 | 84 | 2 | M47468 | |
| Pathway | REACTOME_HEMOSTASIS | CEACAM5 CEACAM4 ESAM SLC7A11 CEACAM1 SLC7A9 SYTL4 SDC3 SLC7A5 ATP2A1 JAM3 | 5.55e-04 | 571 | 84 | 11 | MM14472 |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 6.76e-04 | 67 | 84 | 4 | MM15327 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | HFE SLCO2B1 CFTR SLC24A3 SLC35B2 SLC7A11 SLC7A9 SLC8B1 SLC24A4 CLCN7 SLC7A5 ATP2A1 | 6.79e-04 | 681 | 84 | 12 | MM14985 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.23e-04 | 7 | 84 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.23e-04 | 7 | 84 | 2 | M47530 | |
| Pathway | WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A | 7.23e-04 | 7 | 84 | 2 | M42540 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 8.94e-04 | 32 | 84 | 3 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 9.79e-04 | 33 | 84 | 3 | M188 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.23e-03 | 9 | 84 | 2 | MM14527 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.37e-03 | 37 | 84 | 3 | M18615 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.72e-03 | 86 | 84 | 4 | M916 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.79e-03 | 87 | 84 | 4 | M27617 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.85e-03 | 41 | 84 | 3 | M13519 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.86e-03 | 11 | 84 | 2 | M525 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.95e-03 | 89 | 84 | 4 | M39398 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.12e-03 | 43 | 84 | 3 | M12617 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.23e-03 | 12 | 84 | 2 | M14663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.23e-03 | 12 | 84 | 2 | M47529 | |
| Pubmed | IGSF8 LRFN1 CEACAM5 LRFN3 ESAM IGSF11 CEACAM1 TMEM81 LRFN4 LRFN2 LRFN5 NECTIN2 JAM3 | 4.74e-15 | 162 | 109 | 13 | 25826454 | |
| Pubmed | 5.76e-12 | 7 | 109 | 5 | 16828986 | ||
| Pubmed | The SALM/Lrfn family of leucine-rich repeat-containing cell adhesion molecules. | 9.13e-11 | 4 | 109 | 4 | 21736948 | |
| Pubmed | A secreted protein microarray platform for extracellular protein interaction discovery. | 2.52e-10 | 51 | 109 | 7 | 21982860 | |
| Pubmed | A novel family of adhesion-like molecules that interacts with the NMDA receptor. | 3.17e-09 | 7 | 109 | 4 | 16495444 | |
| Pubmed | 3.68e-09 | 117 | 109 | 8 | 17145500 | ||
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 1.39e-08 | 25 | 109 | 5 | 27480238 | |
| Pubmed | Synaptic adhesion-like molecules (SALMs) promote neurite outgrowth. | 2.99e-08 | 3 | 109 | 3 | 18585462 | |
| Pubmed | Selected SALM (synaptic adhesion-like molecule) family proteins regulate synapse formation. | 2.99e-08 | 3 | 109 | 3 | 20410109 | |
| Pubmed | 7.13e-08 | 34 | 109 | 5 | 18848646 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 27272249 | ||
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 1.20e-07 | 4 | 109 | 3 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 1.20e-07 | 4 | 109 | 3 | 27748756 | |
| Pubmed | 1.21e-07 | 15 | 109 | 4 | 25490771 | ||
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 16123136 | ||
| Pubmed | DDX47 IMPA1 HLA-E SLC35B2 MFSD4B ADAM22 HSPA13 SYTL4 NOMO2 NECTIN2 TIMM50 SLC7A5 JAM3 ATP5F1B | 1.74e-06 | 952 | 109 | 14 | 38569033 | |
| Pubmed | 1.76e-06 | 28 | 109 | 4 | 8672132 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 15901826 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 18354207 | ||
| Pubmed | Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. | 2.48e-06 | 9 | 109 | 3 | 23230000 | |
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 10081226 | ||
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 12134058 | ||
| Pubmed | Extensive polymorphism surrounding the murine Ia A beta chain gene. | 8.37e-06 | 13 | 109 | 3 | 6311906 | |
| Pubmed | 8.37e-06 | 13 | 109 | 3 | 9973410 | ||
| Pubmed | Demonstration of a glycoprotein derived from the Ceacam10 gene in mouse seminal vesicle secretions. | 9.73e-06 | 2 | 109 | 2 | 15901639 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 22426988 | ||
| Pubmed | Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. | 9.73e-06 | 2 | 109 | 2 | 33522633 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19715555 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19461083 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27442026 | ||
| Pubmed | Amino acid transporters as emerging therapeutic targets in cancer. | 9.73e-06 | 2 | 109 | 2 | 34091991 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12571236 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35181585 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 30321907 | ||
| Pubmed | Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. | 9.73e-06 | 2 | 109 | 2 | 2050678 | |
| Pubmed | HLA-F complex without peptide binds to MHC class I protein in the open conformer form. | 9.73e-06 | 2 | 109 | 2 | 20483783 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20566682 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 12885340 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15102925 | ||
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 9.73e-06 | 2 | 109 | 2 | 17196930 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29760215 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15905509 | ||
| Pubmed | Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer. | 9.73e-06 | 2 | 109 | 2 | 25862890 | |
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 9.73e-06 | 2 | 109 | 2 | 20739275 | |
| Pubmed | 1.06e-05 | 14 | 109 | 3 | 3860873 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MPZ SLCO2B1 CFTR SLC7A11 CLCN7 SYTL4 NECTIN2 SLC7A5 JAM3 EPHA1 | 1.27e-05 | 569 | 109 | 10 | 30639242 |
| Pubmed | 1.33e-05 | 15 | 109 | 3 | 20410265 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 1.63e-05 | 16 | 109 | 3 | 11284729 | |
| Pubmed | 1.97e-05 | 17 | 109 | 3 | 16595723 | ||
| Pubmed | 1.97e-05 | 17 | 109 | 3 | 31676858 | ||
| Pubmed | 2.07e-05 | 105 | 109 | 5 | 30280653 | ||
| Pubmed | Tracts of high or low sequence divergence in the mouse major histocompatibility complex. | 2.36e-05 | 18 | 109 | 3 | 6098460 | |
| Pubmed | Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | 2.80e-05 | 19 | 109 | 3 | 2576007 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10430630 | ||
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 2.91e-05 | 3 | 109 | 2 | 30093493 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 9693107 | ||
| Pubmed | Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. | 2.91e-05 | 3 | 109 | 2 | 3378834 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16179339 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 28740236 | ||
| Pubmed | Comparative genomic aspects of rat, mouse and human MHC class I gene regions. | 2.91e-05 | 3 | 109 | 2 | 11173841 | |
| Pubmed | Removal of Qa-2 antigen alters the Ped gene phenotype of preimplantation mouse embryos. | 2.91e-05 | 3 | 109 | 2 | 1327207 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 34847408 | ||
| Pubmed | Fine map of a region homologous to the rat grc complex in the TL region of the mouse. | 2.91e-05 | 3 | 109 | 2 | 8428772 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10985962 | ||
| Pubmed | CTL and sequence analyses of MHC class IB antigens Qa1(c) (H2-T23(r)) and Qa1(d) (H2-T23(f)). | 2.91e-05 | 3 | 109 | 2 | 10369933 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 17610859 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 7561093 | ||
| Pubmed | Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing. | 2.91e-05 | 3 | 109 | 2 | 18028286 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8319975 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18322080 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 1865393 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12847252 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 3593832 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 3004940 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 25409014 | ||
| Pubmed | Murine MHC class Ib gene, H2-M2, encodes a conserved surface-expressed glycoprotein. | 2.91e-05 | 3 | 109 | 2 | 15045471 | |
| Pubmed | HMT, encoded by H-2M3, is a neoclassical major histocompatibility class I antigen. | 2.91e-05 | 3 | 109 | 2 | 8464890 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 8245452 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 18996482 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 27315375 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 10208972 | ||
| Pubmed | BLyF, a novel cell-type- and stage-specific regulator of the B-lymphocyte gene mb-1. | 2.91e-05 | 3 | 109 | 2 | 1545794 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 2831142 | ||
| Pubmed | Two "Qa" specificities: Qa-m7 and Qa-m8 defined by monoclonal antibodies. | 2.91e-05 | 3 | 109 | 2 | 6190932 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 2581893 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 34911745 | ||
| Pubmed | Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements. | 2.91e-05 | 3 | 109 | 2 | 8753857 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12620187 | ||
| Pubmed | Expression in L cells of transfected class I genes from the mouse major histocompatibility complex. | 2.91e-05 | 3 | 109 | 2 | 2991930 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 22064717 | ||
| Pubmed | Polymorphism within a TCRAV family influences the repertoire through class I/II restriction. | 2.91e-05 | 3 | 109 | 2 | 9570535 | |
| Pubmed | Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. | 2.91e-05 | 3 | 109 | 2 | 33682011 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 33020145 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 7819451 | ||
| Pubmed | Novel mRNA species from a Q-subregion class-I gene of the murine major histocompatibility complex. | 2.91e-05 | 3 | 109 | 2 | 3443307 | |
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 30970256 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 12874228 | ||
| Pubmed | 2.91e-05 | 3 | 109 | 2 | 16570139 | ||
| Pubmed | Role of the Ped gene and apoptosis genes in control of preimplantation development. | 2.91e-05 | 3 | 109 | 2 | 9604770 | |
| Pubmed | Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes. | 2.91e-05 | 3 | 109 | 2 | 35925520 | |
| Interaction | CEACAM21 interactions | 8.35e-09 | 81 | 103 | 8 | int:CEACAM21 | |
| Interaction | BRICD5 interactions | 6.79e-07 | 194 | 103 | 9 | int:BRICD5 | |
| Interaction | TMEM106A interactions | 1.54e-06 | 214 | 103 | 9 | int:TMEM106A | |
| Interaction | ECEL1 interactions | 5.72e-06 | 134 | 103 | 7 | int:ECEL1 | |
| Interaction | CLEC4A interactions | 1.47e-05 | 103 | 103 | 6 | int:CLEC4A | |
| Interaction | HLA-DRB3 interactions | 2.38e-05 | 67 | 103 | 5 | int:HLA-DRB3 | |
| Interaction | SGCA interactions | 2.50e-05 | 113 | 103 | 6 | int:SGCA | |
| Interaction | CEACAM5 interactions | 4.53e-05 | 14 | 103 | 3 | int:CEACAM5 | |
| Interaction | HLA-E interactions | 5.28e-05 | 79 | 103 | 5 | int:HLA-E | |
| Interaction | APOM interactions | 6.81e-05 | 43 | 103 | 4 | int:APOM | |
| Cytoband | 19q13.2 | 2.83e-06 | 164 | 109 | 6 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LRFN1 CEACAM5 FPR2 LRFN3 CEACAM3 CEACAM4 CEACAM1 SLC7A9 SIGLEC7 NECTIN2 TIMM50 | 1.30e-04 | 1192 | 109 | 11 | chr19q13 |
| Cytoband | 11q22.1 | 4.99e-04 | 14 | 109 | 2 | 11q22.1 | |
| Cytoband | 12p13.1 | 1.14e-03 | 21 | 109 | 2 | 12p13.1 | |
| Cytoband | 12q24.13 | 1.62e-03 | 25 | 109 | 2 | 12q24.13 | |
| Cytoband | 6p21.3 | 3.05e-03 | 250 | 109 | 4 | 6p21.3 | |
| Cytoband | 11q23 | 3.34e-03 | 36 | 109 | 2 | 11q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 3.52e-03 | 37 | 109 | 2 | chr4q23 | |
| GeneFamily | Adenosine receptors|V-set domain containing | IGSF8 MPZ PDCD1 CEACAM5 CEACAM3 CEACAM4 ESAM CEACAM1 SIGLEC7 SCN2B NECTIN2 JAM3 | 5.83e-12 | 163 | 79 | 12 | 590 |
| GeneFamily | Solute carriers | SLCO2B1 SLC24A3 SLC35B2 SLC35G6 SLC7A11 SLC7A9 SLCO5A1 SLC8B1 SLC24A4 SLC7A5 SLC37A2 SLC16A11 | 1.37e-07 | 395 | 79 | 12 | 752 |
| GeneFamily | C1-set domain containing | 1.05e-06 | 42 | 79 | 5 | 591 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 3.36e-06 | 24 | 79 | 4 | 906 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.60e-06 | 161 | 79 | 7 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IGSF8 PDCD1 CEACAM5 CEACAM3 CEACAM1 SIGLEC7 NECTIN2 SLC7A5 ENPEP | 5.42e-05 | 394 | 79 | 9 | 471 |
| GeneFamily | Fibronectin type III domain containing | 7.13e-05 | 160 | 79 | 6 | 555 | |
| GeneFamily | Guanylate cyclases, soluble | 1.12e-04 | 4 | 79 | 2 | 820 | |
| GeneFamily | Immunoglobulin like domain containing | 1.99e-04 | 193 | 79 | 6 | 594 | |
| GeneFamily | Alcohol dehydrogenases | 5.19e-04 | 8 | 79 | 2 | 397 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 9.35e-04 | 44 | 79 | 3 | 588 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.16e-03 | 27 | 79 | 2 | 47 | |
| GeneFamily | CD molecules|Tetraspanins | 9.12e-03 | 33 | 79 | 2 | 768 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_100 | 1.17e-05 | 29 | 104 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_100_k2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 173 | 108 | 8 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 173 | 108 | 8 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-08 | 181 | 108 | 8 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-08 | 181 | 108 | 8 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.53e-08 | 182 | 108 | 8 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-08 | 187 | 108 | 8 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-08 | 187 | 108 | 8 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-08 | 129 | 108 | 7 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.04e-07 | 171 | 108 | 7 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-07 | 177 | 108 | 7 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-07 | 178 | 108 | 7 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-07 | 185 | 108 | 7 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.48e-07 | 185 | 108 | 7 | 8f843badc0e26cb7300c83db56c7974beb90fcf3 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-07 | 185 | 108 | 7 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-07 | 186 | 108 | 7 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-07 | 186 | 108 | 7 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-07 | 186 | 108 | 7 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-07 | 188 | 108 | 7 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-07 | 190 | 108 | 7 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-07 | 190 | 108 | 7 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-07 | 190 | 108 | 7 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-07 | 192 | 108 | 7 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-07 | 192 | 108 | 7 | a804cb101c3a5585f72217e1143584b1ca436724 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.64e-07 | 193 | 108 | 7 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.64e-07 | 193 | 108 | 7 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.14e-07 | 196 | 108 | 7 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-07 | 198 | 108 | 7 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.89e-07 | 200 | 108 | 7 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-06 | 158 | 108 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-06 | 159 | 108 | 6 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-06 | 160 | 108 | 6 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-06 | 162 | 108 | 6 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-06 | 165 | 108 | 6 | 3d14f37b8a9c0ddc1130e60a2e08556bad1fb855 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.71e-06 | 170 | 108 | 6 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 172 | 108 | 6 | 850e4c9e9003807c19695be4b13121b0808a9389 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 172 | 108 | 6 | 018d8160cfcb7882475620dc678f48a69a0f643e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 175 | 108 | 6 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 178 | 108 | 6 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.83e-06 | 178 | 108 | 6 | 850fcd368c4478c57eaedc74544773ea220f41f3 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-06 | 178 | 108 | 6 | a16857da9f2907c176213a326112a1b4cbd0e628 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 179 | 108 | 6 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.66e-06 | 183 | 108 | 6 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.84e-06 | 184 | 108 | 6 | a5d904dd030d9c21be0f8b9ec432025f90fb5b8e | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.84e-06 | 184 | 108 | 6 | 7617a00b2ebd6c5c9386c39a7e8220fdbf8669ff | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 6.81e-06 | 189 | 108 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 7.01e-06 | 190 | 108 | 6 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 7.01e-06 | 190 | 108 | 6 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | Healthy_donor-Platelet|World / disease group, cell group and cell class (v2) | 7.23e-06 | 191 | 108 | 6 | defae87313d6345e3f451250fd66fe8831bb441c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.67e-06 | 193 | 108 | 6 | d0dcc0c11ccf99ff6b07e456d25b9742649aadd8 | |
| ToppCell | COVID-19_Severe-Platelet|COVID-19_Severe / disease group, cell group and cell class | 7.67e-06 | 193 | 108 | 6 | d9c2d2f72f9ea01e089f5d769801bcd7de4da617 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-06 | 195 | 108 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | 3'-Child04-06|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-06 | 197 | 108 | 6 | 5da92d069bb32ede5e8f30c5b68c4d0790373467 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-06 | 197 | 108 | 6 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-06 | 197 | 108 | 6 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.87e-06 | 198 | 108 | 6 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.87e-06 | 198 | 108 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | COVID-19_Severe-Neu_3|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 1.25e-05 | 123 | 108 | 5 | 4c20c025b6f19f075a13282288fc537e6e186217 | |
| ToppCell | COVID-19_Severe-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.30e-05 | 124 | 108 | 5 | 54b42ffb161eece4ae308782e43a0e0dc360281e | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 135 | 108 | 5 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Inhba_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.17e-05 | 74 | 108 | 4 | 29d94713d97ac44e0f83d2f3609a719650e20d0f | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-05 | 152 | 108 | 5 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 153 | 108 | 5 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 153 | 108 | 5 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-05 | 158 | 108 | 5 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-05 | 160 | 108 | 5 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.53e-05 | 81 | 108 | 4 | 20796e59cdeb398e7772f4356578d74a33405f71 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 4.57e-05 | 161 | 108 | 5 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 165 | 108 | 5 | fbd84f211ad645c91b9f45a0815391606f3206ac | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 165 | 108 | 5 | 6fbdfacb49e627712ac999d40ae22dcb390edd3e | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 168 | 108 | 5 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 168 | 108 | 5 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 169 | 108 | 5 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 170 | 108 | 5 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | 510625bd725d3590cffcd7acd1d42219f6eb1139 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 171 | 108 | 5 | 4a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-05 | 172 | 108 | 5 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | 4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 175 | 108 | 5 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.96e-05 | 176 | 108 | 5 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | droplet-Liver-LIVER-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 4d2fb51e71bed0d72f3d7f89d395744860885a5f | |
| Computational | Genes in the cancer module 143. | 7.67e-05 | 14 | 66 | 3 | MODULE_143 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 50 | 66 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Drug | AC1L1G3W | ACO2 CFTR GGT5 ADH6 ADH7 ADRA1D GUCY1A2 GUCY1B1 PRKG2 ATP2A1 ATP5F1B | 1.59e-08 | 237 | 107 | 11 | CID000003514 |
| Drug | repaglinide | 1.48e-07 | 11 | 107 | 4 | ctd:C072379 | |
| Drug | CTK8F9183 | 2.25e-07 | 55 | 107 | 6 | CID010176637 | |
| Drug | sodium | IMPA1 SLCO2B1 CFTR DUOX2 SLC24A3 SLC7A11 SLC7A9 PHEX SLC8B1 TSPAN16 SLC24A4 SCN2B ABCB11 SLC7A5 PRKG2 ATP2A1 UEVLD | 1.90e-06 | 944 | 107 | 17 | CID000000923 |
| Drug | zinc protoporphyrin | 2.22e-06 | 126 | 107 | 7 | CID000027287 | |
| Drug | tetraethylarsonium | 3.81e-06 | 23 | 107 | 4 | CID005289426 | |
| Drug | AC1MMLID | 4.81e-06 | 92 | 107 | 6 | CID000013245 | |
| Drug | spermine NONOate | 1.01e-05 | 61 | 107 | 5 | CID000005259 | |
| Drug | arginine hydroxamate | 1.18e-05 | 10 | 107 | 3 | CID000151275 | |
| Drug | alpha-cyano-4-hydroxycinnamate | 1.70e-05 | 33 | 107 | 4 | CID000002102 | |
| Drug | metoxuron | 2.12e-05 | 71 | 107 | 5 | CID000029863 | |
| Drug | Lincomycin | 2.19e-05 | 2 | 107 | 2 | ctd:D008034 | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 2.22e-05 | 179 | 107 | 7 | 1176_UP | |
| Drug | Uroguanylin | 2.42e-05 | 36 | 107 | 4 | CID005488765 | |
| Drug | dl-cystine | 3.19e-05 | 128 | 107 | 6 | CID000000595 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | 3.48e-05 | 192 | 107 | 7 | 5575_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; HL60; HG-U133A | 3.72e-05 | 194 | 107 | 7 | 1556_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 3.84e-05 | 195 | 107 | 7 | 3078_UP | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 3745_UP | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 6480_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 6615_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 7093_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 6648_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 6042_DN | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 4293_UP | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; PC3; HG-U133A | 4.23e-05 | 198 | 107 | 7 | 1900_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 3287_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 7185_UP | |
| Drug | benserazide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 4.37e-05 | 199 | 107 | 7 | 641_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 3570_UP | |
| Drug | Polysorbates | 4.41e-05 | 15 | 107 | 3 | ctd:D011136 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 4.51e-05 | 200 | 107 | 7 | 2314_UP | |
| Drug | DEANO | 4.94e-05 | 43 | 107 | 4 | CID000163608 | |
| Drug | AC1L1IPV | 4.94e-05 | 43 | 107 | 4 | CID000004683 | |
| Drug | guanylin | 5.42e-05 | 44 | 107 | 4 | CID005489468 | |
| Drug | Rodorubicine | 6.54e-05 | 3 | 107 | 2 | CID000057097 | |
| Drug | KB-R7943 | 7.04e-05 | 47 | 107 | 4 | CID004534086 | |
| Drug | Imipenem | 7.82e-05 | 18 | 107 | 3 | ctd:D015378 | |
| Drug | BMS-186282 | 8.64e-05 | 95 | 107 | 5 | CID000002416 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.18e-04 | 233 | 107 | 7 | CID000005114 | |
| Drug | L-Cystine | 1.30e-04 | 4 | 107 | 2 | DB00138 | |
| Drug | latanoprost | 1.30e-04 | 4 | 107 | 2 | ctd:C072042 | |
| Drug | 2-phenylglycine | 1.31e-04 | 55 | 107 | 4 | CID000003866 | |
| Drug | indazole | 1.40e-04 | 56 | 107 | 4 | CID000009221 | |
| Drug | hydride | PECR ACO2 CFTR ETFDH DUOX2 ADH6 ADH7 TSPAN16 GUCY1A2 GRHPR GUCY1B1 ATP2A1 ATP5F1B | 1.49e-04 | 835 | 107 | 13 | CID000000783 |
| Drug | tert-butyl acetate | 1.61e-04 | 58 | 107 | 4 | CID000010908 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.86e-04 | 176 | 107 | 6 | 1638_UP | |
| Drug | methylglucamine | 2.09e-04 | 62 | 107 | 4 | CID000004049 | |
| Drug | indigo carmine | 2.15e-04 | 25 | 107 | 3 | CID005282429 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.16e-04 | 181 | 107 | 6 | 5578_UP | |
| Drug | DL-arginine | 2.23e-04 | 344 | 107 | 8 | CID000000232 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.43e-04 | 185 | 107 | 6 | 1022_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.43e-04 | 185 | 107 | 6 | 4365_DN | |
| Drug | nitroxyl | 2.43e-04 | 185 | 107 | 6 | CID000000945 | |
| Drug | HgCl2 | 2.47e-04 | 263 | 107 | 7 | CID000024085 | |
| Drug | N-methyl-DL-aspartic acid | LRFN3 DDO SLC35B2 ADAM22 ADRA1D LRFN2 TSPAN16 GUCY1A2 GUCY1B1 PRKG2 EPHA1 | 2.61e-04 | 655 | 107 | 11 | CID000004376 |
| Drug | potassium | IMPA1 CFTR SLC24A3 SLC7A11 GGT5 SLC8B1 SLC24A4 GUCY1A2 CLCN7 GUCY1B1 NAXD SLC7A5 PRKG2 ATP2A1 | 2.67e-04 | 1008 | 107 | 14 | CID000000813 |
| Drug | Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A | 2.97e-04 | 192 | 107 | 6 | 5812_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.97e-04 | 192 | 107 | 6 | 5607_UP | |
| Drug | niflumic acid | 3.13e-04 | 125 | 107 | 5 | CID000004488 | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; HL60; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 2527_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 6769_UP | |
| Drug | semustine; Up 200; 100uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 7487_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 6039_DN | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 2804_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 4434_UP | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 3.22e-04 | 195 | 107 | 6 | 207_UP | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 6006_UP | |
| Drug | diclofenac sodium; Up 200; 10uM; PC3; HG-U133A | 3.22e-04 | 195 | 107 | 6 | 445_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 2907_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.22e-04 | 195 | 107 | 6 | 3272_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4974_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 2951_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4167_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5404_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5536_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 3461_UP | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 3473_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5686_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 7432_UP | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; PC3; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4087_UP | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5629_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 7337_UP | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 4156_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 2324_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 1528_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 4017_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 6619_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 4822_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 4488_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 5512_UP | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3316_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 4766_UP | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3307_UP | |
| Drug | Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 2274_UP | |
| Drug | copper(II) sulfate pentahydrate; Up 200; 100uM; MCF7; HG-U133A | 3.40e-04 | 197 | 107 | 6 | 575_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 6664_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 6506_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 6495_UP | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 3537_DN | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.11e-05 | 2 | 99 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.11e-05 | 2 | 99 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 5.18e-05 | 119 | 99 | 5 | EFO_0009268, MONDO_0004975 | |
| Disease | serum metabolite measurement | DDX47 ETFDH L2HGDH SLC24A3 MFSD4B SLC7A11 SLC7A9 ADH7 ADRA1D NECTIN2 SLC7A5 ENPEP | 7.78e-05 | 945 | 99 | 12 | EFO_0005653 |
| Disease | family history of Alzheimer’s disease | 9.75e-05 | 71 | 99 | 4 | EFO_0009268 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 1.11e-04 | 5 | 99 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | choreatic disease (is_implicated_in) | 1.11e-04 | 5 | 99 | 2 | DOID:12859 (is_implicated_in) | |
| Disease | esophageal carcinoma | 1.39e-04 | 30 | 99 | 3 | EFO_0002916 | |
| Disease | serum iron measurement | 2.05e-04 | 86 | 99 | 4 | EFO_0006332 | |
| Disease | lymphedema, filarial elephantiasis | 2.31e-04 | 7 | 99 | 2 | EFO_0007272, MONDO_0019297 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 2.31e-04 | 7 | 99 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | cholesteryl ester 18:0 measurement | 2.41e-04 | 36 | 99 | 3 | EFO_0010343 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.08e-04 | 8 | 99 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.95e-04 | 9 | 99 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | liver cirrhosis (is_implicated_in) | 4.10e-04 | 43 | 99 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | HMG CoA reductase inhibitor use measurement | 4.49e-04 | 189 | 99 | 5 | EFO_0009932 | |
| Disease | peptidoglycan recognition protein 1 measurement | 4.93e-04 | 10 | 99 | 2 | EFO_0020624 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 6.00e-04 | 114 | 99 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | forced expiratory volume, body mass index | 6.01e-04 | 11 | 99 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 7.27e-04 | 120 | 99 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 8.48e-04 | 13 | 99 | 2 | C0369183 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 8.48e-04 | 13 | 99 | 2 | DOID:676 (is_implicated_in) | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 8.48e-04 | 13 | 99 | 2 | C1261502 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 8.72e-04 | 126 | 99 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | aspartate aminotransferase measurement | HFE FLNB PLB1 HLA-DQA1 HECTD4 ETFDH L2HGDH ADH7 ABCB11 FAM118A | 9.23e-04 | 904 | 99 | 10 | EFO_0004736 |
| Disease | psychosis | 9.88e-04 | 14 | 99 | 2 | EFO_0005407 | |
| Disease | narcolepsy-cataplexy syndrome | 1.04e-03 | 59 | 99 | 3 | MONDO_0016158 | |
| Disease | transferrin saturation measurement | 1.30e-03 | 16 | 99 | 2 | EFO_0006333 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.43e-03 | 144 | 99 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.44e-03 | 66 | 99 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | high altitude adaptation | 1.47e-03 | 17 | 99 | 2 | EFO_0009105 | |
| Disease | mean arterial pressure | 1.48e-03 | 499 | 99 | 7 | EFO_0006340 | |
| Disease | lupus nephritis (is_implicated_in) | 1.65e-03 | 18 | 99 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | multiple sclerosis (is_implicated_in) | 1.92e-03 | 73 | 99 | 3 | DOID:2377 (is_implicated_in) | |
| Disease | insulin measurement | 2.09e-03 | 267 | 99 | 5 | EFO_0004467 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 2.24e-03 | 21 | 99 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | total iron binding capacity | 2.32e-03 | 78 | 99 | 3 | EFO_0006334 | |
| Disease | Colorectal Neoplasms | 2.45e-03 | 277 | 99 | 5 | C0009404 | |
| Disease | Colorectal Carcinoma | 2.53e-03 | 702 | 99 | 8 | C0009402 | |
| Disease | alcohol drinking | 2.59e-03 | 81 | 99 | 3 | EFO_0004329 | |
| Disease | serum alanine aminotransferase measurement | HFE HLA-DQA1 HECTD4 L2HGDH TSC22D2 LRFN2 NECTIN2 ABCB11 ATP5F1B | 2.61e-03 | 869 | 99 | 9 | EFO_0004735 |
| Disease | metabolite measurement | 2.83e-03 | 560 | 99 | 7 | EFO_0004725 | |
| Disease | psoriatic arthritis | 3.17e-03 | 87 | 99 | 3 | EFO_0003778 | |
| Disease | intermediate density lipoprotein measurement | 3.17e-03 | 87 | 99 | 3 | EFO_0008595 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.28e-03 | 181 | 99 | 4 | DOID:684 (is_implicated_in) | |
| Disease | cervical carcinoma | 3.34e-03 | 182 | 99 | 4 | EFO_0001061 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAGILTVKGGTGAIV | 251 | Q99798 | |
| TCVVFGLGGVGLSVI | 206 | P40394 | |
| GSSIGVQSAVIVGGI | 116 | Q9H0S4 | |
| RGLTGGEIVAVIFGL | 541 | P21709 | |
| GILNGVAAFVIVGIG | 516 | Q9P2K9 | |
| GAVAGIVTGVLVGVA | 151 | O75871 | |
| TTGEGEGRVGIILTL | 1121 | P13569 | |
| TLGIIGLGRVGQAVA | 176 | Q13363 | |
| VLGEGGILSTVQGIT | 211 | P59827 | |
| GAGIVESIGEGVSTV | 71 | P28332 | |
| GATVGIMIGVLVGVA | 686 | P06731 | |
| AGAVLVAAIVLGGTG | 741 | O75078 | |
| GVAGTNIIIGIIAGT | 731 | Q9P0K1 | |
| ISVSPLIGIGAATIG | 246 | O95342 | |
| ALGLSVGLVGIVVGT | 221 | P01909 | |
| GIVATTGVGTEIGKI | 221 | O14983 | |
| AGAATGRIVAVIGAV | 56 | P06576 | |
| VFITHGDVGVGTIVG | 161 | Q8NFF2 | |
| GLVVLGAVVTGAVVA | 311 | P30511 | |
| GGTMIIIIGGIIVAS | 526 | Q96NI6 | |
| LLVSAVGLGVATAGG | 116 | Q96LR9 | |
| VGLGVATAGGAVTIT | 121 | Q96LR9 | |
| GAGLLGPAVVTAAVV | 6 | Q5JPE7 | |
| GLVLLGSVVSGAVVA | 311 | P13747 | |
| GLVGVGGVVQATGLV | 366 | Q8NCK7 | |
| TGIVFGAILGAILGV | 236 | Q8N387 | |
| IVIVGGGIVGLASAR | 51 | Q9H9P8 | |
| VVLGVTFVLGVLGNG | 31 | P25090 | |
| FLGGTMIIAIGGVIV | 531 | Q9P244 | |
| VLAVIGGVDAGLRVG | 2306 | Q15751 | |
| KFEVSVLVGGGIGVT | 1376 | Q9NRD8 | |
| VSGVILSVVGGLAVG | 231 | P51798 | |
| VVTRGAGIGGLGITV | 1351 | O75369 | |
| FQTLVVGVVGGLLGS | 166 | Q15116 | |
| GAIIGSGIFVTPTGV | 61 | Q8MH63 | |
| GAVIGIAVLGSLVVA | 756 | Q5VY43 | |
| AIVTGGATGIGKAIV | 21 | Q9BY49 | |
| GAGTAVAGAVVVALL | 6 | Q8IW45 | |
| GTIIGSGIFVTPTGV | 61 | Q01650 | |
| IGIHTGEVVTGVIGQ | 521 | Q02153 | |
| GGTMIIALGGVIVAS | 536 | Q9BTN0 | |
| VVGVGLIVGLAVGLT | 26 | Q07075 | |
| NIGGIIGGVLVVLAV | 241 | Q9BX67 | |
| PSGTLVIGVISGIAV | 301 | Q30201 | |
| GAISGLVGPLSTIVV | 201 | Q96R45 | |
| QVLGRGISGSIGVVA | 1751 | Q9Y4D8 | |
| IATLGVGGFGRVELV | 456 | Q13237 | |
| VFITKGDVGVGTIVG | 171 | Q9HC58 | |
| GVSIGILDTGGNVLI | 96 | Q5TF39 | |
| GAISGLVGPLSTIVV | 201 | O95047 | |
| IAVVGAGVVGLSTAV | 6 | Q99489 | |
| ATLGLGGVAVVLGAV | 666 | Q9UHC9 | |
| TGSFVGGIVLTLGVL | 166 | Q8N131 | |
| LSTLFDVGGIIGGIV | 336 | Q8TED4 | |
| DVGGIIGGIVAGLVS | 341 | Q8TED4 | |
| LLVIGTGVSAAVAPG | 31 | Q9NWS6 | |
| VVIVGAGPAGLSAAV | 71 | Q16134 | |
| GLIAGAIGTGAVIII | 241 | Q5DX21 | |
| VGTGVALVTGATVLG | 586 | Q969P0 | |
| GLIAVTATGAVAGVA | 476 | P61570 | |
| LAILTGTVEVGTGAG | 246 | Q13520 | |
| SPGAIAGIVIGVVAL | 426 | P13688 | |
| GLISGISIIVGTIIG | 31 | P82251 | |
| LTQSTVGIIGLGRIG | 151 | Q9UBQ7 | |
| TGNLVGIVVGGVGEA | 171 | Q58HT5 | |
| VIGGAGGELIISAVA | 486 | P36269 | |
| GAVAGIVTGVLVGVA | 151 | P40198 | |
| GAAVVAGAVVGTLVG | 246 | Q96AP7 | |
| GGEGGVIITQFIAII | 21 | Q8N6U8 | |
| VVTGVAIQAGIDGGS | 436 | P48723 | |
| LVAVIVGGVVGALFA | 386 | O75056 | |
| SGSIVLVIVLAGVGV | 306 | Q95460 | |
| DAVVKIGTGFGLGIV | 16 | Q5TGZ0 | |
| GAGVLVTTVVAGGIT | 176 | Q6J4K2 | |
| GIHSGSVLAGVVGVR | 616 | P33402 | |
| GSGGQRVITIVTDGV | 266 | Q8TAK5 | |
| IAVVGASGVGKTALV | 36 | Q9BPW5 | |
| VRLGVGTGISNGEVV | 616 | Q96C24 | |
| SGLGATGGSVVVVVA | 216 | O75157 | |
| VAHLGGVAVGITLGV | 341 | P58872 | |
| VAGAGIIVTEAGGVL | 221 | P29218 | |
| EVGVATALGILVVAG | 136 | Q9UL19 | |
| VIIVPSAGVGIVLGG | 476 | Q9H2Y9 | |
| VTGGVISGIGKGIIA | 6 | P17812 | |
| VLLGAVGGAGATALV | 351 | Q9Y286 | |
| EIGDGTTGVVVLAGA | 101 | P48643 | |
| PVAAGVGLVVGIIGT | 1421 | Q6P1J6 | |
| AVGGLVVSAQGVGVG | 86 | P25100 | |
| FVAVSGIILVGLGIG | 21 | Q9UKR8 | |
| SIIIGTIIGAGIFIS | 51 | Q9UPY5 | |
| VTGGVISGIGKGIIA | 6 | Q9NRF8 | |
| IVGASVGGFLAVVIL | 161 | O60939 | |
| AGLLGAGGTVSVVYI | 71 | Q3ZCQ8 | |
| TGQVGLGGEVVVLAK | 486 | Q96KV7 | |
| GLVSGFVSGITGIVT | 2966 | Q96RL7 | |
| TVVGGLGVAVVFAAL | 391 | Q8TB61 | |
| LSFPSVIVGIVVGGV | 416 | O94956 | |
| IRTFAVAIVGVGGVG | 71 | Q9GZZ9 | |
| VAIVGVGGVGSVTAE | 76 | Q9GZZ9 | |
| GGAVGTVGRLNITVV | 46 | Q9H0E2 | |
| SSIHIIGGVIAVGVF | 41 | Q12999 | |
| IALVVFVGGTLVLGT | 21 | P78562 | |
| VGGAAGVVSRITGSV | 3471 | Q709C8 | |
| VGAGVVLGSIAIITA | 311 | P0C7Q6 | |
| SALGIGIAIGVVGGV | 226 | Q6P7N7 | |
| GGVTVVGLVSSLLGG | 216 | Q96HH6 | |
| TVNKITVVGGGELGI | 181 | Q8IX04 | |
| AGVVATVLAVLGLGG | 31 | A0A0U1RRA0 | |
| GGTMILVIGGIIVAT | 531 | Q9ULH4 | |
| AHVLGGTLTVAVGGV | 511 | Q6PJG9 | |
| GTLTVAVGGVLVAAL | 516 | Q6PJG9 | |
| VVLGAVIGGVLGVVL | 156 | P25189 | |
| GATGGIIGGIIAAII | 356 | Q92692 |